NCT00538395Unknown不适用
Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
适应症
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 主要终点
- Effectiveness
研究概览
简要总结
Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with locally advanced breast cancer
排除标准
- 未提供
结局指标
主要结局
Effectiveness
时间窗: overall
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast CancerBreast CancerNCT00546156Ian E. Krop, MD, PhD104
撤回
1 期
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast CancerBreast CancerNCT00022230Roger Williams Medical Center
已完成
2 期
Combination Chemotherapy in Treating Patients With High-Risk Breast CancerBreast CancerNCT00004092City of Hope Medical Center72
已完成
2 期
Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast CancerBreast NeoplasmsBreast CancerNCT00001239National Cancer Institute (NCI)100
Unknown
不适用
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's SarcomaEwing's SarcomaNCT00541411King Faisal Specialist Hospital & Research Center10